A new analysis from KFF shows that for the first time since the enhanced premium tax credits were introduced in 2021, insurer participation in the Affordable Care Act Marketplaces has

Most patients who undergo a combined upper and lower GI endoscopy think of it as one procedure. In clinical terms, it is two: an esophagogastroduodenoscopy examining the upper tract, followed

Prostate cancer can be treated with targeted therapies, but there are still opportunities to improve on this approach. MultiValent Biotherapies is going after two validated cancer targets with a single

InStride Health, a pediatric mental health provider, announced Monday that it raised $30 million in Series C funding to expand into new markets. Boston-based InStride Health provides virtual specialty outpatient

As clinical drug development becomes more complex and resource-intensive, the FDA’s recent draft guidance on the use of Bayesian statistical methods in clinical trials signals a move toward more adaptive

AI is rapidly gaining traction in the health insurance industry. But according to one health insurance executive, AI shouldn’t be used for the “sake of AI,” but to empower what

One healthcare finance executive thinks the U.S. healthcare system is on a path toward separate and unequal care. Multicare CFO James Lee said the math that has held the system

The road to interoperability is long, but not impossible. In healthcare, this decades-long effort to improve data sharing has already seen successes, like standardized information-sharing practices and the shift away

Healthcare costs in the U.S. are growing faster than inflation, and the U.S. spends significantly more than other comparable nations on healthcare. And according to one healthcare executive, this is

Rocket Pharmaceuticals sold its rare disease pediatric priority review voucher for $180 million, cash that the company will use to support a pipeline now led by a gene therapy in